China and Europe are accelerating the deregulation of the US FDA

With the advent of a new era of data, advanced algorithms are used to meet the challenge of prescription development

Roll dead! GLP-1 drug upstream raw materials surging

China's drug administration speed, FIC new drugs are only four months behind the United States was approved for marketing

Pharmaceutical trends: exchanging assets is also a lifeline

The future of Treg: CAR-Treg